8-K - Catalyst Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events On June 1, 2025, Gary Ingenito, MD, PhD, the Chief Medical and Regulatory Officer of Catalyst Pharmaceuticals, Inc. (the “ Company ”) retired from

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued by the Company on June 2, 2025. 104 Cover Page Interactive Data File (embedded within

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1